Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-08

Clinical Trial Update: A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) [Phase 3]

View source ↗

Summary

AWARD-4, a Phase 3 trial in adults with type 2 diabetes mellitus, has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2014-10-08